DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,054 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,042 | +6.5% | 8,231 | +3.2% | 0.14% | +10.0% |
Q2 2023 | $1,917 | -4.8% | 7,978 | 0.0% | 0.13% | -9.7% |
Q1 2023 | $2,013 | -5.0% | 7,978 | 0.0% | 0.14% | -9.4% |
Q4 2022 | $2,120 | -99.9% | 7,978 | 0.0% | 0.16% | -3.0% |
Q3 2022 | $2,063,000 | +1.9% | 7,978 | 0.0% | 0.16% | +5.8% |
Q2 2022 | $2,025,000 | -14.9% | 7,978 | -1.5% | 0.16% | -4.9% |
Q1 2022 | $2,379,000 | -14.6% | 8,103 | -4.2% | 0.16% | -11.9% |
Q4 2021 | $2,785,000 | +8.1% | 8,458 | 0.0% | 0.18% | -3.6% |
Q3 2021 | $2,577,000 | +33.5% | 8,458 | -1.2% | 0.19% | +22.3% |
Q2 2021 | $1,930,000 | 0.0% | 8,558 | 0.0% | 0.16% | 0.0% |
Q1 2021 | $1,930,000 | -0.6% | 8,558 | -2.0% | 0.16% | -6.5% |
Q4 2020 | $1,942,000 | +3.1% | 8,733 | -0.1% | 0.17% | +2.4% |
Q3 2020 | $1,884,000 | +21.9% | 8,740 | +0.1% | 0.16% | +9.3% |
Q2 2020 | $1,546,000 | +26.3% | 8,733 | -1.1% | 0.15% | +5.6% |
Q1 2020 | $1,224,000 | -12.2% | 8,833 | -2.6% | 0.14% | +8.4% |
Q4 2019 | $1,394,000 | +6.2% | 9,073 | 0.0% | 0.13% | -3.0% |
Q3 2019 | $1,312,000 | +1.1% | 9,073 | 0.0% | 0.14% | -1.5% |
Q2 2019 | $1,298,000 | +8.3% | 9,073 | 0.0% | 0.14% | +2.2% |
Q1 2019 | $1,199,000 | +26.2% | 9,073 | -1.4% | 0.13% | +12.6% |
Q4 2018 | $950,000 | -6.1% | 9,198 | -1.1% | 0.12% | +9.2% |
Q3 2018 | $1,012,000 | +31.3% | 9,298 | +19.2% | 0.11% | +23.9% |
Q2 2018 | $771,000 | +0.8% | 7,798 | 0.0% | 0.09% | -1.1% |
Q1 2018 | $765,000 | +5.7% | 7,798 | 0.0% | 0.09% | +4.7% |
Q4 2017 | $724,000 | +4.2% | 7,798 | -3.7% | 0.08% | -1.2% |
Q3 2017 | $695,000 | +1.8% | 8,098 | 0.0% | 0.09% | -1.1% |
Q2 2017 | $683,000 | -1.4% | 8,098 | 0.0% | 0.09% | -2.2% |
Q1 2017 | $693,000 | -45.0% | 8,098 | -50.0% | 0.09% | +2.3% |
Q4 2016 | $1,260,000 | +98.4% | 16,196 | +100.0% | 0.09% | -7.4% |
Q3 2016 | $635,000 | -25.8% | 8,098 | -4.4% | 0.09% | -25.4% |
Q2 2016 | $856,000 | -1.3% | 8,473 | -7.3% | 0.13% | -3.1% |
Q1 2016 | $867,000 | +4.0% | 9,141 | +1.8% | 0.13% | +6.6% |
Q4 2015 | $834,000 | +6.2% | 8,981 | -2.5% | 0.12% | -1.6% |
Q3 2015 | $785,000 | -4.6% | 9,213 | -4.2% | 0.12% | -3.1% |
Q2 2015 | $823,000 | +0.9% | 9,613 | 0.0% | 0.13% | +4.1% |
Q1 2015 | $816,000 | -1.0% | 9,613 | 0.0% | 0.12% | -3.1% |
Q4 2014 | $824,000 | -10.4% | 9,613 | -20.6% | 0.13% | -13.0% |
Q3 2014 | $920,000 | -8.3% | 12,113 | -4.9% | 0.15% | -8.2% |
Q2 2014 | $1,003,000 | +5.0% | 12,738 | 0.0% | 0.16% | 0.0% |
Q1 2014 | $955,000 | -2.4% | 12,738 | +0.6% | 0.16% | -3.6% |
Q4 2013 | $978,000 | +9.3% | 12,663 | -2.0% | 0.16% | +2.5% |
Q3 2013 | $895,000 | +9.4% | 12,915 | 0.0% | 0.16% | +5.9% |
Q2 2013 | $818,000 | +10.8% | 12,915 | -28.9% | 0.15% | -18.7% |
Q3 2010 | $738,000 | +9.5% | 18,170 | 0.0% | 0.19% | +6.2% |
Q2 2010 | $674,000 | – | 18,170 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |